ARTICLE | Company News
CytoDyn, Progenics deal
October 22, 2012 7:00 AM UTC
CytoDyn completed its acquisition of Progenics' PRO 140 and related assets to treat HIV/AIDS infection for $3.5 million in cash. Progenics is also eligible for a $1.5 million milestone payment upon t...